Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D05IRV
|
|||
Former ID |
DNCL002284
|
|||
Drug Name |
Elesclomol
|
|||
Synonyms |
Elesclomol; 488832-69-5; Elesclomol (STA-4783); STA-4783; UNII-6UK191M53P; CHEBI:79369; 6UK191M53P; Propanedioic acid, bis[2-methyl-2-(phenylthioxomethyl)hydrazide]; 1,3-Bis[2-methyl-2-(phenylthioxomethyl)hydrazide]propanedioic acid; N'1,N'3-dimethyl-N'1,N'3-di(phenylcarbonothioyl)malonohydrazide; J-503879; C19H20N4O2S2; 1-N'-Benzenecarbothioyl-3-(2-benzenecarbothioyl-2-methylhydrazinyl)-N'-methyl-oxopropanehydrazidide; Elesclomol [USAN:INN]; elesclomolum
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Acute myeloid leukaemia [ICD-11: 2A60] | Phase 3 | [1] | |
Company |
Synta Pharmaceuticals
|
|||
Structure |
Download2D MOL |
|||
Formula |
C19H20N4O2S2
|
|||
Canonical SMILES |
CN(C(=S)C1=CC=CC=C1)NC(=O)CC(=O)NN(C)C(=S)C2=CC=CC=C2
|
|||
InChI |
1S/C19H20N4O2S2/c1-22(18(26)14-9-5-3-6-10-14)20-16(24)13-17(25)21-23(2)19(27)15-11-7-4-8-12-15/h3-12H,13H2,1-2H3,(H,20,24)(H,21,25)
|
|||
InChIKey |
BKJIXTWSNXCKJH-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 488832-69-5
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
445356, 4961563, 8878120, 11405824, 14903649, 34840127, 56310613, 56311705, 56311707, 56311723, 56314499, 56314500, 56314501, 78846313, 96025592, 104253159, 104508134, 109692983, 121366288, 124756965, 124894520, 125163770, 125333917, 126644893, 126730750, 131465122, 134223637, 134964384, 135253516, 137262617, 137275831, 143293764, 144115935, 152258362, 152344345, 160647200, 160693441, 162011888, 162037406, 163884618, 175427028, 177748843, 185990437, 198952107, 223444544, 223705191, 224575110, 226652581, 235465277, 241084633
|
|||
ChEBI ID |
CHEBI:79369
|
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT00522834) Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.